Are you living with dementia due to Alzheimer’s disease? Join the XanaMIA study 

People with dementia due to Alzheimer’s disease may be eligible for a clinical research trial investigating if an oral once-daily tablet can help with memory. Space in this study is limited. 

When a loved one is experiencing symptoms of Alzheimer’s disease it can be difficult to comprehend or even talk about. Clinical research trials in Alzheimer’s help deepen our understanding of this debilitating disease. If you’re experiencing signs of memory loss, difficulty completing daily tasks, or misplacing things, you may qualify for the XanaMIAclinical research trial. Find out how to get involved today. 

Eligible Participants Are: 

50 years of age or older 

Experiencing signs of dementia due to Alzheimer's Disease 

Have a reliable study partner who can attend study visits 

Additional criteria may apply 

Eligible Participants May: 

Receive compensation for study related time and travel 

See a physician or medical staff for study related care at no cost